Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales declined 8.95% to Rs 358.85 crore in the quarter ended June 2024 as against Rs 394.12 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 358.85 | 394.12 | -9 |
| OPM % | 11.09 | 9.02 | - |
| PBDT | 20.38 | 18.39 | 11 |
| PBT | 4.92 | 3.06 | 61 |
| NP | 2.97 | 1.82 | 63 |